President Donald Trump is planning big tariffs on pharmaceuticals, kitchen counters, bathroom vanities, upholstered furniture and heavy trucks.| AP News
While more large employers are covering GLP-1 drugs for weight loss, KFF's conversations with employers highlight concerns about the cost of these medications. Many of these employers have considered scaling back coverage of GLP-1 agonists for weight loss, or in some cases, employers are adding or strengthening coverage requirements.| KFF
Family premiums for employer-sponsored health insurance reached an average of $26,993 this year, KFF’s annual benchmark health benefits survey of large and smaller employers finds. On average, workers contribute $6,850 annually to the cost of family coverage, with employers paying the rest.| KFF
This brief analyzes changes in the new tax and budget reconciliation law that modify which drugs will be selected for Medicare drug price negotiation, which will lead to higher Medicare spending and higher costs for beneficiaries who take these medications.| KFF
Medicare for All would take the profit motive out of insurance; public manufacturing of prescription drugs would take it out of providing care.| The American Prospect
As Robert F. Kennedy Jr. reshapes federal vaccine policy and guidelines, NC physicians talk about practical effects and frustration.| North Carolina Health News
‘In addition to not being very safe, these drugs also make sleep quality worse in ways that may be detrimental to brain health.’| Sleep Review
Compass Pathways has been aggressively using patent claims to corner the market on psychedelic-assisted treatments.| The American Prospect
On average, the new Medicare negotiated drug prices are 2.8 times the average of drug prices in 11 OECD countries of similar size and wealth.| Peterson-KFF Health System Tracker
In their ongoing quest to lower prescription drug prices, some states are forcing drugmakers to continue to sell cheaper medications to thousands of pharmacies through a federal drug-discount program.| Stateline
This chart collection explores how health spending is expected to grow in coming years. In 2024, per capita health spending growth is estimated to have slowed to 4.5%.| Peterson-KFF Health System Tracker
This analysis of survey data finds that over 40% of adults under 65 with private insurance could be indicated for a GLP-1 drug though relatively few have a claim, suggesting that a much smaller share seeks treatment through healthcare providers.| Peterson-KFF Health System Tracker
This analysis uses the Merative MarketScan 2022 commercial claims to estimate the number of enrollees in the employer-sponsored insurance market who use one or more of the ten drugs selected for Medicare Part D price negotiations.| Peterson-KFF Health System Tracker
The U.S. spends more on healthcare per capita than its peers. Most of the additional health spending goes to providers for inpatient and outpatient care.| Peterson-KFF Health System Tracker
Urban and rural communities have come to depend on pharmacies as a trusted care option and a place for advice.| AP News
An Associated Press analysis of licensing data from 44 states, data from the National Council for Prescription Drug Programs and the American Community Survey shows residents of neighborhoods that are majority Black and Latino have fewer pharmacies per capita than people who live in mostly white nei| AP News
Drugs solely approved to treat obesity have minimal to no coverage on most ACA Marketplace plans. Wegovy, a semaglutide approved for weight loss, is included in just 1% of Marketplace plans, while Ozempic, which has the same active ingredient but is approved for diabetes treatment and sometimes used off-label for weight loss, is included in 82% of Marketplace plan formularies. Among ACA Marketplace plans with these drugs on formulary, prior authorization is required by most plans. All plans ...| Peterson-KFF Health System Tracker
Although most adults are in good health and have health insurance, more than 1 in 4 adults (28%) reported delaying or foregoing healthcare due to cost.| Peterson-KFF Health System Tracker